Variant forms of bladder cancer: basic considerations on treatment approaches

Area of Science:

• Uro-oncology
• Cancer Histopathology
• Clinical Oncology

Background:

• Variant bladder cancers encompass non-urothelial neoplasms and mixed urothelial carcinomas.
• These variants typically present at advanced stages and higher grades compared to pure urothelial carcinoma.
• Limited evidence exists for optimal treatment due to their rarity and exclusion from clinical trials.

Purpose of the Study:

• To review existing literature on variant bladder cancer forms.
• To focus on the most frequent histological subtypes.
• To provide a basis for treatment recommendations.

Main Methods:

• Literature review of case series and existing reports.
• Focus on identifying and summarizing data for common variant types.
• Analysis of prognostic and therapeutic information.

Main Results:

• Variant bladder cancers present with aggressive features (high stage/grade).
• Prognosis varies significantly among different variant types.
• Common variants include squamous cell, adenocarcinoma, small cell, micropapillary, sarcomatoid, and lymphoepithelioma-like.

Conclusions:

• Variant bladder cancers require careful consideration due to aggressive presentation.
• Evidence-based treatment guidelines are limited; case series offer initial insights.
• Further research and inclusion in trials are needed for these rare entities.